Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: Experience of a single institution in Japan

International Journal of Hematology

Volumn 85, Issue 3, 2007, Pages 238-241

  Tomonari, Akira ^a   Takahashi, Satoshi ^a   Ooi, Jun ^a   Tsukada, Nobuhiro ^a   Konuma, Takaaki ^a   Kobayashi, Takeshi ^a   Sato, Aki ^a   Takasugi, Kashiya ^a   Iseki, Tohru ^a   Tojo, Arinobu ^a   Asano, Shigetaka ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b WASEDA UNIVERSITY   (Japan)

Author keywords

Antibiotics; Bacteremia; Bloodstream infection; Cord blood transplantation; Myeloablative; Neutropenia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CYCLOSPORIN; MEROPENEM; METHOTREXATE; PANIPENEM PLUS BETAMIPRON; PIPERACILLIN; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOSUFLOXACIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTEREMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG SUBSTITUTION; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM POSITIVE BACTERIUM; HUMAN; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; RISK FACTOR; SEPSIS;

ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; CORD BLOOD STEM CELL TRANSPLANTATION; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION CONDITIONING;

EID: 34247588712     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.06179     Document Type: Article

References (11)

1. Wingard JR, Leather HL. Bacterial infections. In: Blume KG, Forman SJ, Appelbaum FR, eds. Thomas' Hematopoietic Cell Transplantation. Oxford, UK: Blackwell Scientific Publications; 2004:665-682.
2. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
3. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004; 351:2265-2275.
4. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276-2285.
5. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104:3813-3820.
6. Tomonari A, Iseki T, Ooi J, et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol. 2003; 121:304-311.
7. Collin BA, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis. 2001; 33:947-953.
8. Narimatsu H, Matsumura T, Kami M, et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant. 2005;11:429-436.
9. Saavedra S, Sanz GF, Jarque I, et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant. 2002;30:937-943.
10. Hamza NS, Lisgaris M, Yadavalli G, et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol. 2004; 124:488-498.
11. Junghanss C, Marr KA, Carter RA, et al. Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. Biol Blood Marrow Transplant. 2002;8:512-520.